alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 7,451–7,475 of 27,380 studies, newest first · page 299 of 1096.

August 2023 14

  1. 2023-08-07

    A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment

    ✓ Peer-reviewed Biomarkers Annals of clinical and translational neurology

    Key finding: A 95% (347/366) concordance rate was noted between clinicians' patient selection and the test's intended use criteria. +4 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2023-08-04

    The gut microbiota-brain axis in neurological disorder

    ✓ Peer-reviewed Disease mechanisms Frontiers in neuroscience

    Key finding: Increasing preclinical and clinical studies/evidence indicate that gut microbes are a possible susceptibility factor for the progression of neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS) and autism spectrum disorder (ASD).

    Full summary, score breakdown and related studies → Original source

  3. 2023-08-03

    Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact

    ✓ Peer-reviewed Treatments Alzheimer's research & therapy

    Key finding: Crude AD prevalence (2015-2020) was estimated at 760.5 per 100,000 inhabitants, and age-standardized prevalence (2020) was 664.6 (male 595.7, female 711.0). +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2023-08-03

    Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks

    ✓ Peer-reviewed Treatments Frontiers in aging neuroscience

    Key finding: It causes cognitive dysfunction, such as aphasia and agnosia, and mental symptoms, such as behavioral abnormalities; all of which place a significant psychological and economic burden on the patients' families. +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2023-08-03

    Advanced brain imaging for the diagnosis of Alzheimer disease

    ✓ Peer-reviewed Biomarkers Current opinion in neurology

    Key finding: The purpose is to review the latest advances of brain imaging for the diagnosis of Alzheimer disease (AD). +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2023-08-03

    Plasma neurofilament light chain in relation to 10-year change in cognition and neuroimaging markers: a population-based study

    ✓ Peer-reviewed Biomarkers GeroScience

    Key finding: Higher plasma NfL was associated with worse cognitive performance at baseline (g-factor: β = - 0.12 (- 0.15; - 0.09), p < 0.001), and accelerated cognitive decline during follow-up on the Stroop color naming task (β = 0.04 (0.02; 0.06), p < 0.001), with a smaller trend for decline in global cognition (g-factor β = - 0.02 (- 0.04; 0.00), p = 0.044). +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2023-08-02

    Neurovascular glial unit: A target of phytotherapy for cognitive impairments

    ✓ Peer-reviewed Inflammation and the immune system Phytomedicine : international journal of phytotherapy and phytopharmacology

    Key finding: Herbal medicines demonstrate great potential to prevent cognitive impairment.

    Full summary, score breakdown and related studies → Original source

  8. 2023-08-02

    Factors associated with medication adherence in older adults: The atherosclerosis risk in communities study

    ✓ Peer-reviewed Risk factors Journal of the American Geriatrics Society

    Key finding: We examined factors associated with self-reported medication nonadherence in well-characterized community-based cohort of older adults. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2023-08-02

    Association Between Socioeconomic Factors, Race, and Use of a Specialty Memory Clinic

    ✓ Peer-reviewed Risk factors Neurology

    Key finding: 4,824 patients seen at the memory clinic between 2008-2018 were included in this study (mean age 72.7 [standard deviation 11.0] years, 2,712 [56%] female, 543 [11%] Black). +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2023-08-02

    Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis

    ✓ Peer-reviewed TREM2 and immune genetics Hepatology (Baltimore, Md.)

    Key finding: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease for which pharmacological treatment options are currently unavailable. +3 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2023-08-01

    Objectively Measured Visual Impairment and Dementia Prevalence in Older Adults in the US

    ✓ Peer-reviewed Cognitive tests and assessment JAMA ophthalmology

    Key finding: In this survey study, all types of objectively measured VI were associated with a higher dementia prevalence. +1 more finding

    Full summary, score breakdown and related studies → Original source

  12. 2023-08-01

    Considering Questions Before Methods in Dementia Research With Competing Events and Causal Goals

    ✓ Peer-reviewed Long-term cohort studies American journal of epidemiology

    Key finding: Researchers often interpret death as a potential source of bias, although bias cannot be defined or assessed if the causal question is not explicitly specified. +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2023-08-01

    A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Cell stem cell

    Key finding: Much controversy exists around the complex and multifaceted pathogenesis of this prevalent disease. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2023-08-01

    Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

    ✓ Peer-reviewed Treatments JAMA

    Key finding: Among 1736 randomized participants (mean age, 73.0 years; 996 [57.4%] women; 1182 [68.1%] with low/medium tau pathology and 552 [31.8%] with high tau pathology), 1320 (76%) completed the trial. +2 more findings

    Full summary, score breakdown and related studies → Original source

July 2023 11

  1. 2023-07-31

    Healthcare Utilization and Advance Care Planning among Older Adults Across Cognitive Levels

    ✓ Peer-reviewed End-of-life care Journal of applied gerontology : the official journal of the Southern Gerontological Society

    Key finding: The results showed that having an ACP was associated with longer stays in hospitals, nursing homes, and home healthcare in all participants.

    Full summary, score breakdown and related studies → Original source

  2. 2023-07-31

    ‘Good, honest food’: older adults' and healthcare professionals' perspectives of dietary influences and food preferences in older age in Ireland

    ✓ Peer-reviewed Risk factors Journal of Human Nutrition and Dietetics

    Key finding: A total of 47 adults aged 55+ years were recruited (50% male; 49% aged 60-69 years; 28% aged above 70 years), and 26 HCPs were involved, comprising dietitians (n = 8); geriatricians (n = 6); clinical therapists (n = 4); and nurses, pharmacists, catering managers and meal delivery service coordinators (n = 2 each). +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2023-07-30

    Plasma-derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community-based study

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: P-tau181 (odds ratio [OR] 2.06, 95% confidence interval [CI] 1.41-3.00, p < 0.001), p-tau217 (OR 1.70, 95% CI 1.10-2.61, p = 0.016), and t-tau (OR 1.44, 95% CI 1.08-1.92, p = 0.012) were associated with appetite change. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2023-07-29

    Blood-Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework

    ✓ Peer-reviewed Biomarkers International journal of molecular sciences

    Key finding: Our data showed that there was no difference in BBB dysfunction across different ATN subtypes, and that BBB damage was not correlated with cognitive impairment. +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2023-07-29

    Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years

    ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy

    Key finding: The use of PRSs may be beneficial for increased precision in risk estimates among APOE4 carriers. +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2023-07-29

    Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

    ✓ Peer-reviewed Tau biomarkers Molecular neurodegeneration

    Key finding: Disease-modifying drug use necessitates better Alzheimer disease (AD) detection. +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2023-07-29

    The many "Neurofaces" of Prohibitins 1 and 2: Crucial for the healthy brain, dysregulated in numerous brain disorders

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of chemical neuroanatomy

    Key finding: Prohibitin 1 (PHB1) and prohibitin 2 (PHB2) are proteins that are nearly ubiquitously expressed. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2023-07-28

    TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease

    ✓ Peer-reviewed TREM2 and immune genetics Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    Key finding: However, there is no specific treatment to mechanistically inhibit the progression of Alzheimer's disease, and most drugs only provide symptom relief and do not fundamentally reverse AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2023-07-27

    Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum

    ✓ Peer-reviewed Long-term cohort studies Neurology

    Key finding: Choroid plexus (ChP) is emerging as a key brain structure in the pathophysiology of neurodegenerative disorders. +3 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2023-07-26

    Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Given that these new antiamyloid monoclonal antibodies (mAbs) are associated with nontrivial risks and burdens of treatment that are radically different from current mainstays of AD management, effectively and equitably translating their use to real-world clinical care will require systematic and practice-specific modifications to existing workflows and infrastructure.

    Full summary, score breakdown and related studies → Original source

  11. 2023-07-26

    Improving the Bioavailability and Efficacy of Coenzyme Q10 on Alzheimer's Disease Through the Arginine Based Proniosomes

    ✓ Peer-reviewed Tau biomarkers Journal of pharmaceutical sciences

    Key finding: CoQ10 plays a role in membrane stability, energy conversion, and ATP production. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →